A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus. (Q51355720)
Jump to navigation
Jump to search
scientific article published on 4 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus. |
scientific article published on 4 July 2012 |
Statements
A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus. (English)
1 reference
K E Truitt
1 reference
H S Chou
1 reference
J B Moberly
1 reference
D Merante
1 reference
Y Choi
1 reference
Y Mun
1 reference
A Pfützner
1 reference
4 July 2012
1 reference
14
1 reference
11
1 reference
1000-1009
1 reference
1 reference